Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

BGI-challenger Yikon Genomics Secures over CNY 220 Million
BGI-challenger Yikon Genomics Secures over CNY 220 Million
Image: Credit to The Honest Company on Unsplash

Rising awareness of the importance of maternal and child health has boosted the demand for embryo screening analyses globally. Yikon Genomics (亿康基因) has been offering genetic tests to help parents navigate heritable genetic problems since its establishment in 2002.

A unique demographic structure, the ‘relaxed’ family planning policies of Beijing from 2016 onwards and the rise of the 'new middle class' has created a new wave of demand for maternal services in China.

Yikon is offering a series of next-generation genetic tests: PGT-M and PGT-A. These tests support maternal and child health as well as helping personalized cancer therapies. Yet, the company claimed that it is also shifting its attention towards maternal health.

BGI Genomics (300676: SH), China's largest genome sequencing-company, has long been the most significant Chinese figure in the global Non-Invasive Prenatal Testing (NIPT) Market, challenging its peer from the US, Illumina (ILMN: NASDAQ).

Yikon Genomics, a small player in an arena dominated by giants, claims to have a 97%+ success rate on Non-Invasive PGT-A embryos, with an even higher rate for day 5/6 embryos. Yikon urges the clinics “not to miss the chance of ordering now.” Yet it is common amongst PGT-A and PGT-M tests providers to claim over 98% percent accuracy.

The leading investor of the Series C funding round, Jinhe Capital (金阖资本) is a KingMed Diagnostics (603882: SH)-backed fund. The Vice President of Jinhe Capital, Hao Bixi (郝必喜), has stated his commitment to providing genetic diagnosis services “for all Chinese,” yet he did not mention an overseas market expansion plan.

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 800,000 of your peers